Nuclear envelope rupture and repair during cancer cell migration CM Denais, RM Gilbert, P Isermann, AL McGregor, M Te Lindert, ... Science 352 (6283), 353-358, 2016 | 1197 | 2016 |
Interstitial leukocyte migration and immune function P Friedl, B Weigelin Nature immunology 9 (9), 960-969, 2008 | 659 | 2008 |
Intravital third harmonic generation microscopy of collective melanoma cell invasion: Principles of interface guidance and microvesicle dynamics B Weigelin, GJ Bakker, P Friedl IntraVital 1 (1), 32-43, 2012 | 380 | 2012 |
Third harmonic generation microscopy of cells and tissue organization B Weigelin, GJ Bakker, P Friedl Journal of Cell Science 129 (2), 245-255, 2016 | 263 | 2016 |
Preclinical intravital microscopy of the tumour-stroma interface: invasion, metastasis, and therapy response S Alexander, B Weigelin, F Winkler, P Friedl Current opinion in cell biology 25 (5), 659-671, 2013 | 166 | 2013 |
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity B Weigelin, AT den Boer, E Wagena, K Broen, H Dolstra, RJ de Boer, ... Nature communications 12 (1), 5217, 2021 | 141 | 2021 |
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb B Weigelin, E Bolaños, A Teijeira, I Martinez-Forero, S Labiano, ... Proceedings of the National Academy of Sciences 112 (24), 7551-7556, 2015 | 115 | 2015 |
Cytotoxic T lymphocyte migration and effector function in the tumor microenvironment B Weigelin, M Krause, P Friedl Immunology letters 138 (1), 19-21, 2011 | 87 | 2011 |
Lévy-like movement patterns of metastatic cancer cells revealed in microfabricated systems and implicated in vivo S Huda, B Weigelin, K Wolf, KV Tretiakov, K Polev, G Wilk, M Iwasa, ... Nature communications 9 (1), 4539, 2018 | 86 | 2018 |
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer C Hinterleitner, J Strähle, E Malenke, M Hinterleitner, M Henning, ... Nature communications 12 (1), 7005, 2021 | 83 | 2021 |
Tracking targeted bimodal nanovaccines: immune responses and routing in cells, tissue, and whole organism LJ Cruz, PJ Tacken, IS Zeelenberg, M Srinivas, F Bonetto, B Weigelin, ... Molecular pharmaceutics 11 (12), 4299-4313, 2014 | 56 | 2014 |
The Potential of In Vivo Imaging for Optimization of Molecular and Cellular Anti-cancer Immunotherapies GO Fruhwirth, M Kneilling, IJM de Vries, B Weigelin, M Srinivas, ... Molecular Imaging and Biology 20, 696-704, 2018 | 35 | 2018 |
A large‐scale 19F MRI‐based cell migration assay to optimize cell therapy F Bonetto, M Srinivas, B Weigelin, LJ Cruz, A Heerschap, P Friedl, ... NMR in Biomedicine 25 (9), 1095-1103, 2012 | 31 | 2012 |
T cell-mediated additive cytotoxicity–death by multiple bullets B Weigelin, P Friedl Trends in cancer 8 (12), 980-987, 2022 | 25 | 2022 |
The cohesin-interacting protein, precocious dissociation of sisters 5A/sister chromatid cohesion protein 112, is up-regulated in human astrocytic tumors C Hagemann, B Weigelin, S Schommer, M Schulze, N Al-Jomah, ... International journal of molecular medicine 27 (1), 39-51, 2011 | 24 | 2011 |
Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage? B Weigelin, E Bolaños, ME Rodriguez-Ruiz, I Martinez-Forero, P Friedl, ... Cancer Immunology, Immunotherapy 65, 493-497, 2016 | 22 | 2016 |
A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes B Weigelin, P Friedl Biochemical pharmacology 80 (12), 2087-2091, 2010 | 21 | 2010 |
Recent advances in intravital microscopy for preclinical research M Giampetraglia, B Weigelin Current Opinion in Chemical Biology 63, 200-208, 2021 | 14 | 2021 |
Cancer cell elimination by cytotoxic T cell cooperation and additive damage B Weigelin, AT den Boer, E Wagena, K Broen, H Dolstra, RJ de Boer, ... BioRxiv, 2020.04. 22.054718, 2020 | 8 | 2020 |
Adenosine A2a receptor antagonism restores additive cytotoxicity by cytotoxic T cells in metabolically perturbed tumors J Slaats, E Wagena, D Smits, AA Berends, E Peters, GJ Bakker, M van Erp, ... Cancer Immunology Research 10 (12), 1462-1474, 2022 | 7 | 2022 |